Pin1 Contribution to Alzheimer's Disease: Transcriptional and Epigenetic Mechanisms in Patients with Late-Onset Alzheimer's Disease

被引:27
作者
Arosio, B. [1 ]
Bulbarelli, A. [3 ]
Candia, S. Bastias [5 ]
Lonati, E. [3 ]
Mastronardi, L. [1 ]
Romualdi, P. [5 ]
Candeletti, S. [5 ]
Gussago, C. [1 ]
Galimberti, D. [2 ]
Scarpini, E. [2 ]
Dell'Osso, B. [2 ]
Altamura, C. [2 ]
Maccarrone, M. [6 ,7 ]
Bergamaschini, L. [4 ]
D'Addario, C. [6 ]
Mari, D. [1 ]
机构
[1] Univ Milan, Geriatr Unit, IT-20122 Milan, Italy
[2] Univ Milan, IRCCS Osped Maggiore Policlin, Dept Neurol Sci, IT-20122 Milan, Italy
[3] Univ Milano Bicocca, Dept Expt Med, Milan, Italy
[4] Univ Milan, ASP Pio Albergo Trivulzio, IT-20122 Milan, Italy
[5] Univ Bologna, Dept Pharmacol, Bologna, Italy
[6] Univ Teramo, Dept Biomed Sci, Teramo, Italy
[7] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy
关键词
Pin1; Alzheimer's disease; Epigenetic mechanisms; Phosphorylation mechanisms; MILD COGNITIVE IMPAIRMENT; PROLYL CIS/TRANS ISOMERASES; PHOSPHORYLATION; NEURODEGENERATION; EXPRESSION; DIAGNOSIS; PROTEINS; POLYMORPHISMS; ISOMERIZATION; BLOOD;
D O I
10.1159/000333799
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neurofibrillary tangles and senile plaques are hallmarks of Alzheimer's disease (AD) although the molecular basis of their coexistence remains elusive. The peptidylprolyl cis/trans isomerase Pin1 acts on both tau and amyloid precursor protein to regulate their functions by influencing tau phosphorylation and amyloid precursor protein processing. Objective: In order to identify potential biomarkers for AD in easily accessible cells and to gain insight into the relationship between the brain and peripheral compartments in AD pathology, we investigated Pin1 expression and activity in the peripheral blood mononuclear cells of subjects with late-onset AD (LOAD) and age-matched controls (CT). Methods: Gene and protein expression, promoter methylation, Ser(16) phosphorylation and activity of Pin1 were evaluated in 32 samples from subjects with LOAD and in 28 samples from CT. Results: In LOAD subjects, there was a statistically significant reduction in Ser(16) phosphorylation (-30%; p = 0.041) and promoter methylation (-8%; p = 0.001), whereas Pin1 expression was significantly increased (+74%; p = 0.018). Conclusion: The modifications of Pin1 found in LOAD subjects support its involvement in the pathogenesis of the disease with an important role being played by epigenetic mechanisms. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:207 / 211
页数:5
相关论文
共 29 条
[1]   Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease [J].
Arosio, B ;
Trabattoni, D ;
Galimberti, L ;
Bucciarelli, P ;
Fasano, F ;
Calabresi, C ;
Cazzullo, CL ;
Vergani, C ;
Annoni, G ;
Clerici, M .
NEUROBIOLOGY OF AGING, 2004, 25 (08) :1009-1015
[2]   Adenosine A2A Receptor Expression in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment [J].
Arosio, Beatrice ;
Viazzoli, Chiara ;
Mastronardi, Luigina ;
Bilotta, Claudio ;
Vergani, Carlo ;
Bergamaschini, Luigi .
JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) :991-996
[3]   Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice [J].
Brecht, WJ ;
Harris, FM ;
Chang, SJ ;
Tesseur, I ;
Yu, GQ ;
Xu, Q ;
Fish, JD ;
Wyss-Coray, T ;
Buttini, M ;
Mucke, L ;
Mahley, RW ;
Huang, YD .
JOURNAL OF NEUROSCIENCE, 2004, 24 (10) :2527-2534
[4]   Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy [J].
Bu, Guojun .
NATURE REVIEWS NEUROSCIENCE, 2009, 10 (05) :333-344
[5]   Tau protein isoforms, phosphorylation and role in neurodegenerative disorders [J].
Buée, L ;
Bussière, T ;
Buée-Scherrer, V ;
Delacourte, A ;
Hof, PR .
BRAIN RESEARCH REVIEWS, 2000, 33 (01) :95-130
[6]   Pin1 affects Tau phosphorylation in response to Aβ oligomers [J].
Bulbarelli, Alessandra ;
Lonati, Elena ;
Cazzaniga, Emanuela ;
Gregori, Maria ;
Masserini, Massimo .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2009, 42 (01) :75-80
[7]   Pin1 in Alzheimer's disease [J].
Butterfield, D. Allan ;
Abdul, Hafiz Mohmmad ;
Opii, Wycliffe ;
Newman, Shelley F. ;
Joshi, Gururaj ;
Ansari, Mubeen Ahmad ;
Sultana, Rukhsana .
JOURNAL OF NEUROCHEMISTRY, 2006, 98 (06) :1697-1706
[8]   Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease [J].
Butterfield, DA ;
Poon, HF ;
Clair, DS ;
Keller, JN ;
Pierce, WM ;
Klein, JB ;
Markesbery, WR .
NEUROBIOLOGY OF DISEASE, 2006, 22 (02) :223-232
[9]   Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria [J].
Dubois, Bruno ;
Feldman, Howard H. ;
Jacova, Claudia ;
Dekosky, Steven T. ;
Barberger-Gateau, Pascale ;
Cummings, Jeffrey ;
Delocourte, Andre ;
Galasko, Douglas ;
Gauthier, Serge ;
Jicha, Gregory ;
Meguro, Kenichi ;
O'Brien, John ;
Pasquier, Florence ;
Robert, Philippe ;
Rossor, Martin ;
Solloway, Steven ;
Stern, Yaakov ;
Visser, Pieter J. ;
Scheltens, Philip .
LANCET NEUROLOGY, 2007, 6 (08) :734-746
[10]   Histone modifications, DNA methylation, and Schizophrenia [J].
Gavin, David P. ;
Sharma, Rajiv P. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2010, 34 (06) :882-888